Antoine Tesniere
Antoine Tesniere
Université Paris Descartes, iLumens
Adresse e-mail validée de ilumens.org
Titre
Citée par
Citée par
Année
Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy
L Apetoh, F Ghiringhelli, A Tesniere, M Obeid, C Ortiz, A Criollo, G Mignot, ...
Nature medicine 13 (9), 1050-1059, 2007
26482007
Calreticulin exposure dictates the immunogenicity of cancer cell death
M Obeid, A Tesniere, F Ghiringhelli, GM Fimia, L Apetoh, JL Perfettini, ...
Nature medicine 13 (1), 54-61, 2007
24422007
Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β–dependent adaptive immunity against tumors
F Ghiringhelli, L Apetoh, A Tesniere, L Aymeric, Y Ma, C Ortiz, ...
Nature medicine 15 (10), 1170-1178, 2009
15122009
Cancer despite immunosurveillance: immunoselection and immunosubversion
L Zitvogel, A Tesniere, G Kroemer
Nature Reviews Immunology 6 (10), 715-727, 2006
14672006
Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death
N Casares, MO Pequignot, A Tesniere, F Ghiringhelli, S Roux, N Chaput, ...
The Journal of experimental medicine 202 (12), 1691-1701, 2005
11302005
Immunogenic death of colon cancer cells treated with oxaliplatin
A Tesniere, F Schlemmer, V Boige, O Kepp, I Martins, F Ghiringhelli, ...
Oncogene 29 (4), 482-491, 2010
7902010
Mechanisms of pre‐apoptotic calreticulin exposure in immunogenic cell death
T Panaretakis, O Kepp, U Brockmeier, A Tesniere, AC Bjorklund, ...
The EMBO journal 28 (5), 578-590, 2009
6572009
The anticancer immune response: indispensable for therapeutic success?
L Zitvogel, L Apetoh, F Ghiringhelli, F André, A Tesniere, G Kroemer
The Journal of clinical investigation 118 (6), 1991-2001, 2008
6132008
Elective surgery cancellations due to the COVID-19 pandemic: global predictive modelling to inform surgical recovery plans
Journal of British Surgery 107 (11), 1440-1449, 2020
5842020
The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy
L Apetoh, F Ghiringhelli, A Tesniere, A Criollo, C Ortiz, R Lidereau, ...
Immunological reviews 220 (1), 47-59, 2007
5562007
Calreticulin exposure is required for the immunogenicity of γ-irradiation and UVC light-induced apoptosis
M Obeid, T Panaretakis, N Joza, R Tufi, A Tesniere, P Van Endert, ...
Cell Death & Differentiation 14 (10), 1848-1850, 2007
4422007
Molecular characteristics of immunogenic cancer cell death
A Tesniere, T Panaretakis, O Kepp, L Apetoh, F Ghiringhelli, L Zitvogel, ...
Cell Death & Differentiation 15 (1), 3-12, 2008
4232008
Contribution of IL-17–producing γδ T cells to the efficacy of anticancer chemotherapy
Y Ma, L Aymeric, C Locher, SR Mattarollo, NF Delahaye, P Pereira, ...
Journal of Experimental Medicine 208 (3), 491-503, 2011
3282011
The co-translocation of ERp57 and calreticulin determines the immunogenicity of cell death
T Panaretakis, N Joza, N Modjtahedi, A Tesniere, I Vitale, M Durchschlag, ...
Cell Death & Differentiation 15 (9), 1499-1509, 2008
3252008
The IKK complex contributes to the induction of autophagy
A Criollo, L Senovilla, H Authier, MC Maiuri, E Morselli, I Vitale, O Kepp, ...
The EMBO journal 29 (3), 619-631, 2010
3222010
Tumor cell death and ATP release prime dendritic cells and efficient anticancer immunity
L Aymeric, L Apetoh, F Ghiringhelli, A Tesniere, I Martins, G Kroemer, ...
Cancer research 70 (3), 855-858, 2010
3202010
Immunogenic cancer cell death: a key-lock paradigm
A Tesniere, L Apetoh, F Ghiringhelli, N Joza, T Panaretakis, O Kepp, ...
Current opinion in immunology 20 (5), 504-511, 2008
3112008
Restoration of the immunogenicity of cisplatin-induced cancer cell death by endoplasmic reticulum stress
I Martins, O Kepp, F Schlemmer, S Adjemian, M Tailler, S Shen, ...
Oncogene 30 (10), 1147-1158, 2011
3082011
Chemotherapy induces ATP release from tumor cells
I Martins, A Tesniere, O Kepp, M Michaud, F Schlemmer, L Senovilla, ...
Cell cycle 8 (22), 3723-3728, 2009
2412009
Molecular interactions between dying tumor cells and the innate immune system determine the efficacy of conventional anticancer therapies
L Apetoh, A Tesniere, F Ghiringhelli, G Kroemer, L Zitvogel
Cancer research 68 (11), 4026-4030, 2008
2292008
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20